Belarusian scientists develop DNA test to assess reproductive health risks

Scientists in Belarus have developed a DNA test that evaluates the risk of reproductive loss through genetic analysis. The new tool enables healthcare professionals to identify inherited factors linked to pregnancy complications and choose appropriate medical strategies, reports Belteleradiocompany, a partner of TV BRICS.

The test examines 26 genes associated with women’s reproductive health. The expanded scope of the analysis provides doctors with a more comprehensive dataset for clinical assessment and decision-making.

Maksim Amelyanovich, Head of the Human Genetics Laboratory at the Institute of Genetics and Cytology of the National Academy of Sciences of Belarus, explained that genetic predispositions may remain dormant for years and are often influenced by environmental conditions. He added that specialists typically prepare results and issue a genetic passport within two weeks.

Compared with the previous version, which covered 14 genes, the updated panel delivers a deeper insight into biological factors that can affect pregnancy outcomes. This allows medical teams to adopt a more personalised approach when supporting patients.

The initiative is part of Belarus’s broader efforts to advance genetic research and personalised healthcare. To date, around 30,000 genetic passports have been issued across the country, contributing to the wider use of genomic data in preventive medicine.

The new test is already being used at the Republican Scientific and Practical Centre "Mother and Child", expanding the range of diagnostic tools available to specialists and supporting families on their path to parenthood.